The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes
Prediabetes, Insulin Resistance, Metabolic Syndrome
About this trial
This is an interventional treatment trial for Prediabetes focused on measuring almonds, pre-diabetes, inflammatory, CRP
Eligibility Criteria
Inclusion Criteria: Age greater than 18 years No self-reported allergy to almonds No history of irritable bowel disease or diverticulitis that could be exacerbated by daily almond intake Presence of pre-diabetes according to the 2005 American Diabetes Association diagnostic guidelines (fasting blood glucose between 100 to 125 mg/dl or casual blood glucose ≥ 140-199 mg/dl) Body mass index (BMI) 20-35 kg/m2 to enhance the generalizability of the study's findings to the population of adults with pre-diabetes Willingness to discontinue vitamin E supplement usage while enrolled in the study. Exclusion Criteria: No concurrent use of corticosteroids or immunosuppressant medications (tacrolimus, cyclosporine, sirolimus, azathioprine, 6-mercaptopurine, mycophenolate mofetil, everolimus) in light of their effect on inflammatory biomarkers No liver disease, renal disease and/or severe dyslipidemia (triglycerides [TG] > 400mg/dl or total cholesterol [TC] > 300 mg/dl)
Sites / Locations
- UMDNJ
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
nut free diet
almond group
ADA recommended diabetes diet without any nuts
calorie controlled diet with prescribed daily amount of almonds